| Lenvatinib Basic information |
| Thyroid cancer drugs Biological activity In vitro study In vivo studies Feature |
| Product Name: | Lenvatinib |
| Synonyms: | 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080;LENVATINIB;E7080 (Lenvatinib);Lenvatinib (E7080);ER-203492-00;1-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide XEN445 |
| CAS: | 417716-92-8 |
| MF: | C21H19ClN4O4 |
| MW: | 426.85 |
| EINECS: | 1592732-453-0 |
| Product Categories: | API ; Inhibitors ; FGF receptor antagonist |
| Mol File: | 417716-92-8.mol |